ライフサイエンスコーパス: hepatectomy

1 artition and Portal Vein Ligation for Staged hepatectomy).

2 unit of autologous blood before living donor hepatectomy.

3 llowed liver function recovery after partial hepatectomy.

4 eration process following two-thirds partial hepatectomy.

5 rioperative outcomes for patients undergoing hepatectomy.

6 r2 knockout (Itpr2(-/-) ) mice following 67% hepatectomy.

7 ion as the primary energy source early after hepatectomy.

8 splantation, ulcerative colitis, and partial hepatectomy.

9 tion and reduced steatosis following partial hepatectomy.

10 e injected with Concanvalin A before partial hepatectomy.

11 Patient overall survival after hepatectomy.

12 lates growth and metabolic adaptations after hepatectomy.

13 drinking water of mice subjected to partial hepatectomy.

14 ia-reperfusion injury and regeneration after hepatectomy.

15 us and overall complications following major hepatectomy.

16 eneration in 157 patients undergoing partial hepatectomy.

17 model of 2-acetylaminofluorene with partial hepatectomy.

18 nd HPC-associated biliary regeneration after hepatectomy.

19 MSCs supported survival after partial hepatectomy.

20 PP treatment delayed liver weight gain after hepatectomy.

21 olization, if used, types of transection and hepatectomy.

22 ignaling, was strongly induced after partial hepatectomy.

23 neration and clinical outcomes after partial hepatectomy.

24 decades, morbidity is still high after major hepatectomy.

25 ers and the in vivo activation after partial hepatectomy.

26 nce to the 10-fold volume removal of partial hepatectomy.

27 elated deaths occurred within 365 days after hepatectomy.

28 nefit from adjuvant CIK cell treatment after hepatectomy.

29 nce to the 10-fold volume removal of partial hepatectomy.

30 ferred to surgical teams to be evaluated for hepatectomy.

31 h higher rate of proliferation after partial hepatectomy.

32 e recovery of the living donor after partial hepatectomy.

33 blockade on liver regeneration after partial hepatectomy.

34 luded all adult patients undergoing elective hepatectomy.

35 nalyze surgeons' anticipation of the risk of hepatectomy.

36 fferent time points until 72 h after partial hepatectomy.

37 generation when applied 2 h prior to partial hepatectomy.

38 ion of SB-258719 sixteen hours after partial hepatectomy.

39 (mitotic index in HE sections) after partial hepatectomy.

40 Wistar rats were subjected to 60-70% partial hepatectomy.

41 hepatectomy liver failure (PHLF) after major hepatectomy.

42 nd 59 of these donors underwent living donor hepatectomy.

43 the selection of patients undergoing partial hepatectomy.

44 lism during liver regeneration after partial hepatectomy.

45 9 proteolytically cleaved VEGF after partial hepatectomy.

46 PHLF remain clinical challenges after major hepatectomy.

47 ent predictive biomarker of PHLF after major hepatectomy.

48 ting similar outcome as other types of major hepatectomies.

49 n display similar safety and feasibility for hepatectomies.

50 tectomy (20%, 23%, 30%, P < 0.0001), 2-stage hepatectomy (0%, 3%, 4%, P < 0.001), need for portal vei

51 evidenced by increases in the rates of major hepatectomy (20%, 23%, 30%, P < 0.0001), 2-stage hepatec

52 Patients were treated with an extended hepatectomy (202 [39.3%]), a hemihepatectomy (180 [35.0%

53 n hemihepatectomy (48.8%), or hemi-/extended hepatectomy (36.3%).

54 eration was compared with that after partial hepatectomy (70%).

55 rsus 16%, open proctectomy 13% vs 17%, major hepatectomy 8% versus 12%, pancreatoduodenectomy 16% ver

56 Most underwent a major hepatectomy (82%), often accompanied by lymphadenectomy

57 Although ALPPS is now an established 2-stage hepatectomy additional data are warranted to further ref

58 w conceptual technique of laparoscopic right hepatectomy allowing for low blood loss and morbidity.

59 ared to 28 and 12 months for patients in the hepatectomy alone group (control).

60 artition and Portal vein ligation for Staged hepatectomy (ALPPS) has been tested in various indicatio

61 artition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) occurred over time and is associated

62 artition and portal vein ligation for staged hepatectomy (ALPPS) show clinically distinct recovery pa

63 artition and portal vein ligation for staged hepatectomy (ALPPS), a 2-stage hepatectomy procedure, ha

64 artition and Portal Vein Ligation for Staged Hepatectomy (ALPPS), available after stage-1, either to

65 Moreover, liver regeneration after partial hepatectomy also depended upon the formation of InsP3 in

66 gment, crystallizable) to mice after partial hepatectomy and acetaminophen intoxication, and measured

67 egeneration, which is required after partial hepatectomy and acute or chronic liver injury.

68 urs prior to and sixteen hours after partial hepatectomy and by intraperitoneal administration of SB-

69 Regenerative growth was induced by partial hepatectomy and exposure to carbon tetrachloride.

70 better 5-year overall survival from initial hepatectomy and from liver recurrence in the PSH than in

71 r transplantation by pure laparoscopic total hepatectomy and liver graft implantation using a preexis

72 The patient underwent total hepatectomy and living donor liver transplantation (LDLT

73 -258719 and SB-269970) at 16 h after partial hepatectomy and peaked at 32 h ([(3)H]-thymidine incorpo

74 of liver regeneration after extended partial hepatectomy and portal vein ligation for multiple biloba

75 y augmented liver regeneration after partial hepatectomy and portal vein ligation, and increased the

76 Epac2 are deleted, were subjected to partial hepatectomy and the regenerating liver was analyzed with

77 mportant to help improve the safety of donor hepatectomy and to provide a database for informed conse

78 suffered from residual biliary calculi after hepatectomy and underwnet POC from August 2016 to June 2

79 ted 20 years ago, has been described for all hepatectomies, and is considered as the reference techni

80 diofrequency (RF) ablation, partial surgical hepatectomy, and a sham operation and to inhibit HCC rec

81 ogram who underwent pancreaticoduodenectomy, hepatectomy, and colectomy at a single academic institut

82 phagectomy, total/partial gastrectomy, major hepatectomy, and pancreatectomy were identified using th

83 She underwent an open right hepatectomy, and pathology surprisingly revealed a bilia

84 of portal hypertension, planned extension of hepatectomy, and the MELD score.

85 ression-free survival, conversion to partial hepatectomy, and viable HCC within the tumor specimen.

86 n otherwise recoverable surgical injury (30% hepatectomy), antibiotics, and a short period of starvat

87 Nonanatomical tissue-sparing hepatectomies are associated with worse DFS in patients

88 We used liver regeneration after partial hepatectomy as a physiological stress response model.

89 h HCC hepatocellular carcinoma who underwent hepatectomy at one institution were evaluated with insti

90 ected from 55 patients who underwent partial hepatectomy at the Royal Infirmary Edinburgh between Dec

91 entially amenable to curative extended right hepatectomy but insufficient size of the future liver re

92 tiple and smaller CRLM, underwent more major hepatectomies, but had less extrahepatic disease.

93 efficient early cytokine response to partial hepatectomy, but is inhibitory to later growth factor ac

94 cal role in liver regeneration after partial hepatectomy, but their role in TCPOBOP-induced direct hy

95 accelerated liver regeneration after partial hepatectomy by 40%, whereas systemic MMP inhibition impa

96 nd of hepatocyte proliferation after partial hepatectomy by preventing increases in growth hormone re

97 p38gamma induces proliferation after partial hepatectomy by promoting the phosphorylation of retinobl

98 hepatectomy performed, and hospital type and hepatectomy caseload were retrieved.

99 Partial hepatectomy causes a transient increase in p21 in a subp

100 s preconditioned with retrorsine and partial hepatectomy, cell transplantation after ETN pretreatment

101 sion-free survival (PFS) for patients in the hepatectomy/CIK combination group were 41 and 16 months,

102 ectomy, pancreatectomy, pulmonary resection, hepatectomy, colectomy, and cystectomy) between 2010 and

103 uperior estimation of patient survival after hepatectomy compared with current staging systems.

104 bited hepatocyte proliferation after partial hepatectomy, confirming its pivotal role in cell cycle p

105 In response to partial hepatectomy, deletion of Epac1 and/or Epac2 led to incre

106 Thus, after two-thirds partial hepatectomy, DeltaEGFR livers displayed lower and delaye

107 Consecutive patients undergoing hepatectomy during 1998 to 2015 at 1 institution were an

108 ALPPS is a novel 2-stage hepatectomy enabling resection of extensive hepatic tumo

109 ortality was similar to conventional 2-stage hepatectomies for CRLM.

110 in 2 expert centers practicing 1- or 2-stage hepatectomy for bCRLM.

111 Outcomes following hepatectomy for BRAF-mut CRLM have not been well studied

112 phagectomy, gastrectomy, pancreatectomy, and hepatectomy for cancer between 2012 and 2017 were identi

113 by next-generation sequencing who underwent hepatectomy for CLM (2005-2015).

114 o stimulate liver regeneration after partial hepatectomy for colorectal liver metastases (CRLM).

115 anuary 1992 and December 2012, who underwent hepatectomy for CRLM and resection of synchronous EHD.

116 All patients who underwent hepatectomy for CRLM with complete resection and known B

117 Of 4124 patients who underwent hepatectomy for CRLM, 1497 had complete resection and kn

118 endent prognostic factor for mortality after hepatectomy for HCC in European patients and could be us

119 All consecutive patients who underwent hepatectomy for HCC in our institution, between February

120 Among 198 patients who underwent hepatectomy for HCC, 109 patients had an available compu

121 ia could be used to evaluate patients before hepatectomy for HCC.

122 Adults who underwent right hepatectomy for LDLT between 2000 and 2018 were analyzed

123 ALPPS is a two-stage hepatectomy for patients with extensive liver tumors wit

124 ging results have been reported with partial hepatectomy for solitary metastases, with percutaneous h

125 ver of wild type mice in response to partial hepatectomy, further supporting a role for these protein

126 ctomy: >=16/yr, pancreatectomy: >=26/yr, and hepatectomy: >=76/yr).

127 erioperative care and surgical technique for hepatectomy have improved, the indications for and compl

128 on-PSH was a risk of noncandidacy for repeat hepatectomy (hazard ratio: 8.18, confidence interval: 1.

129 eplete hepatocyte alphavbeta8, after partial hepatectomy, hepatocyte proliferation and liver-to-body

130 om the hepatic vein during pure laparoscopic hepatectomy; however, there is a risk of pulmonary gas e

131 95% CI: 1.141-6.024; P = 0.024), right-sided hepatectomy (HR: 2.143, 95% CI: 1.544-2.975; P < 0.001),

132 lysis of seven time points following partial hepatectomy identified the epigenetic regulator UHRF1, w

133 del) that underwent RF ablation, 35% partial hepatectomy (ie, left lobectomy), or a sham operation (c

134 ection in 67 consecutive patients with major hepatectomy (ie, resection of >=3 liver segments).

135 to include all patients undergoing elective hepatectomies in an observational study.

136 nsecutive adult patients undergoing elective hepatectomy in 9 HPB centers.

137 in normal and steatotic livers after partial hepatectomy in a rodent model.

138 Hepatectomy in G6PD-deficient donors is associated with

139 hed literature regarding the safety of donor hepatectomy in G6PDd individuals.

140 e and AICAR improved survival after extended hepatectomy in mice challenged with a Western diet, indi

141 on liver regeneration following 70% partial hepatectomy in mice lacking the Cip/Kip inhibitors p21(C

142 nalization also occurred following a partial hepatectomy in mice.

143 accelerated liver regeneration after partial hepatectomy in mice.

144 We have shown that partial hepatectomy in multidrug resistance 2 knockout (Mdr2(-/-

145 n intention-to-treat analysis 1- and 2-stage hepatectomy in patients with bCRLM achieve comparable OS

146 Survival after hepatectomy in patients with double mutation of APC and

147 tation of 2-acetylaminofluorene with partial hepatectomy in rats or on feeding a 3,5-diethoxycarbonyl

148 models of 2-acetylaminofluorene with partial hepatectomy in rats, and 3,5-diethoxycarbonyl-1,4-dihydr

149 iferation that can be observed after partial hepatectomy in rats.

150 stimulating liver regeneration after partial hepatectomy in rodents and humans.

151 were compared between patients who underwent hepatectomy in the eras 1998 to 2003, 2004 to 2009, and

152 On multivariable analysis, hepatectomy in the most recent era 2010 to 2015 was asso

153 We performed partial hepatectomy in WT and liver-specific Sirt1-deficient mic

154 compare liver regeneration upon partial hepatectomy in young and adult mice.

155 ity rates compared with conventional 2-stage hepatectomy including portal vein embolization.

156 The number of hepatectomies increased in each era (794 in 1998 to 2003

157 Major hepatectomy increased PVP by 26.9% (P = 0.001), markedly

158 sts that AhR functionality following partial hepatectomy is dependent on a p21(Cip1)-regulated signal

159 Liver regrowth following partial hepatectomy is enabled by proliferation of hepatocytes t

160 ial for retrievability, and graft removal by hepatectomy is impractical.

161 A second-stage hepatectomy is performed as soon as the graft has regene

162 Two-stage hepatectomy is the surgical strategy mostly chosen for t

163 ious consequences for normal livers, partial hepatectomy leads to severe liver necrosis and reduced h

164 derwent PSH and 144 patients underwent right hepatectomy, left hepatectomy, or left lateral sectionec

165 has enabled extensive liver resection, post-hepatectomy liver failure remains one of the most lethal

166 mathematical framework which described post-hepatectomy liver regeneration in each patient by incorp

167 The pure laparoscopic approach in right hepatectomy (LRH) for living donor liver transplantation

168 Diabetes, repeat-hepatectomy, major-hepatectomy, synchronous-major-proced

169 KRAS-mutated CRLM, more extensive anatomical hepatectomies may be warranted.

170 ent studies of complications following donor hepatectomy may not be generalizable to all hospitals pe

171 During total hepatectomy, median blood loss was 500 mL, and no patien

172 l vein revascularization who underwent lobar hepatectomy, median OS was not reached yet exceeded 24.5

173 To prevent drops in oxygen after hepatectomy, mice were pretreated with inositol trispyro

174 short together with efficient cooling during hepatectomy might improve outcome.

175 The retrorsine-partial hepatectomy model was used for liver repopulation studie

176 In the extended hepatectomy model, liver-selective MMP-9 inhibition rest

177 sed liver repopulation in retrorsine/partial hepatectomy model.

178 After two-thirds partial hepatectomy, mutant mice (n = 5) displayed increased liv

179 ost commonly performed procedure was ex vivo hepatectomy (n = 18), followed by ex vivo resection and

180 65 postoperative days in patients undergoing hepatectomy (n = 2811) and/or pancreatectomy (n = 1092)

181 proctectomy (n = 24,925; median = 6), major hepatectomy (n = 9,805; median = 6), pancreatoduodenecto

182 dent association with LD was found for major hepatectomy (odds ratio [OR], 2.41; 95% CI, 1.17-4.30; P

183 donors undergoing PLDRH and open donor right hepatectomy (ODRH).

184 Partial hepatectomy of the adult mammalian liver activates compe

185 Partial hepatectomy of Uhrf1(HepKO) livers resulted in early and

186 We performed partial hepatectomies on wild-type C57BL/6, CD45.1, Tcrd(-/-), o

187 More specifically, we have performed partial hepatectomy on mice with genetic deficiency in C3, the m

188 of the time from aortic perfusion to end of hepatectomy on outcomes after DCD LT in the United Kingd

189 reased innate immunity in mice after partial hepatectomy or acetaminophen-induced injury, with reside

190 , such as rodent LR after two-thirds partial hepatectomy or administration of damaging chemicals (CCl

191 ional replicative capacity following partial hepatectomy or chemical injuries.

192 Hepatectomy or completion pancreatectomy was accomplishe

193 tocyte proliferation following liver partial hepatectomy or damage resulting from carbon tetrachlorid

194 Thirty-nine patients undergoing partial hepatectomy or liver transplantation for HCC were consen

195 or patients' >/=18 years who underwent wedge hepatectomy or lobectomy from 2000 to 2014.

196 ical more limited resections such as central hepatectomy or sectionectomies may provide an alternativ

197 4 patients underwent right hepatectomy, left hepatectomy, or left lateral sectionectomy (non-PSH grou

198 re it with a successive cohort of open right hepatectomies (ORH) for LDLT.

199 ificantly influenced the risk of death after hepatectomy (P < 0.001) and pancreatectomy (P < 0.001).

200 male sex (P = .03), and no history of prior hepatectomy (P = .04) or hepatic arterial infusion chemo

201 caused higher postresection PVP after right hepatectomy (P = 0.04), the Pringle maneuver was associa

202 er the second procedure, with extended right hepatectomy performed at day 23 after transplantation.

203 sociated conditions, indication for surgery, hepatectomy performed, and hospital type and hepatectomy

204 Recent studies using partial hepatectomy (PH) and other experimental models of liver

205 nd Cdk2 for liver regeneration after partial hepatectomy (PH) by generating corresponding double- and

206 e of cell proliferation that follows partial hepatectomy (PH) identified approximately 1,400 mammalia

207 ), standard (60%), or extended (80%) partial hepatectomy (PH) in mice with and without liver steatosi

208 Extended partial hepatectomy (PH) in patients is leading to portal hyperp

209 intrinsic hepatic innervation after partial hepatectomy (PH) in rats and the presence and pattern of

210 UND & AIMS: Liver regeneration after partial hepatectomy (PH) increases the protein folding burden at

211 during liver regeneration (LR) after partial hepatectomy (PH) is observed in several species.

212 We performed partial hepatectomy (PH) to transgenic mice that overexpress SIR

213 groups) weeks of treatment with G49, partial hepatectomy (PH) was performed, and all mice were mainta

214 iating liver regeneration (LR) after partial hepatectomy (PH), by regulating expression of Cyclin-D1.

215 erent surgical procedures, including partial hepatectomy (PH), intraoperative portal vein ligation (P

216 involved in liver regeneration after partial hepatectomy (PH), to initiate growth, protect liver cell

217 In conjunction with partial hepatectomy (PH), transplanted stem/progenitor cells eng

218 ells during liver regeneration after partial hepatectomy (PH).

219 position was recently reported after partial hepatectomy (PHx) in mice, but the role of fibrin(ogen)

220 a(-/-) (NSG) mice that had undergone partial hepatectomy (PHx) represented the best combination of en

221 aKlf6), cell proliferation following partial hepatectomy (PHx) was increased compared to controls.

222 ytes in culture, rat liver following partial hepatectomy (PHx), and hepatoma cell lines.

223 , we challenged liver function after partial hepatectomy (PHx), inducing acute proliferative and meta

224 liver regeneration after two-thirds partial hepatectomy (PHx).

225 a pneumoniae or Escherichia coli) or partial hepatectomy (PHx).

226 involved in liver regeneration after partial hepatectomy (PHX).

227 Pure laparoscopic donor right hepatectomy (PLDRH) is not a standard procedure for livi

228 urrently used in preclinical models: partial hepatectomy, portal ligature or embolization, and radiot

229 sion, within 1 hour after two-thirds partial hepatectomy (post-PH) in C57BL/6J mice.

230 oling is slow and livers are lukewarm during hepatectomy, potentially affecting outcome.

231 on for staged hepatectomy (ALPPS), a 2-stage hepatectomy procedure, has revolutionized the surgical m

232 PTEN down-regulation after hepatectomy promotes the burning of TRAS-derived lipids

233 gment 2-3 transplantation with delayed total hepatectomy (RAPID) from living donor in a patient affec

234 artition and portal vein ligation for staged hepatectomy." RASPE induced safe and profound growth of

235 cal parenchymal resections including central hepatectomy (resection of segments 4, 5, and 8), right a

236 ificantly between patients in 1- and 2-stage hepatectomy, respectively: 37.2 and 34.5 months (P=0.6),

237 e and inhibition of cell proliferation after hepatectomy, resulting in liver failure.

238 inhibited in DeltaEGFR livers after partial hepatectomy, revealing a new function for EGFR kinase ac

239 A group of 30 patients with minor hepatectomy served as controls.

240 Hepatectomy specimen ex vivo MR imaging assisted in matc

241 ression and liver regeneration after partial hepatectomy, suggesting that DBC1/DN-DBC1 transitions pl

242 Diabetes, repeat-hepatectomy, major-hepatectomy, synchronous-major-procedure, inflow-occlusi

243 frequent use of laparoscopy in living donor hepatectomy, the laparoscopic approach has never been re

244 Following partial hepatectomy, the liver initiates a regenerative program

245 Following partial hepatectomy, the liver initiates a regenerative programm

246 t to surgeons with large experience in donor hepatectomy through a proctored learning curve.

247 (4.9 [3.5-5.9] vs 6.4 [4.3-12]; P < 0.001), hepatectomy time (70 [42-120] vs 81 [58-207]; P = 0.02),

248 No data exist to evaluate how hepatectomy time (HT), in the context of donation after

249 o investigate the relationship between donor hepatectomy time and post-transplant outcome in 12,974 r

250 Donor hepatectomy time had a similar effect on death-censored

251 Donor hepatectomy time impairs liver transplant outcome.

252 were more susceptible to the effect of donor hepatectomy time on death-censored graft survival.

253 Assessing the effect of donor hepatectomy time on outcome after transplantation.

254 Median donor hepatectomy time was 41 minutes [interquartile range (IQ

255 Donor hepatectomy time was defined as time between start of ao

256 Donor hepatectomy time was independently associated with graft

257 s donated after circulatory death had longer hepatectomy times than those from brain-dead donors [50

258 allowed for an increased percentage of major hepatectomies to be performed in a purely minimally inva

259 We performed partial hepatectomies to test liver regeneration and then RNA-se

260 milieu of chronic inflammation links partial hepatectomy to accelerated hepatocarcinogenesis; this su

261 as to evaluate a modified technique of total hepatectomy to limit hazardous liver manipulation and im

262 anvalin A was injected 4 days before partial hepatectomy to natural killer T cells- deficient mice or

263 ral types and rounds of injury, ranging from hepatectomy to toxin-mediated damage.

264 In mice, partial hepatectomy up-regulated expression of CCL20 and ligands

265 ALPPS is a two-stage hepatectomy variant that increases resection rates and R

266 Laparoscopic hepatectomy was associated with lower intraoperative blo

267 A new conceptual technique of right hepatectomy was designed using evidence-based facts and

268 A left hepatectomy was done and dilated bile ducts filled with

269 Most important, LR after partial hepatectomy was impaired in caNrf2-transgenic mice as a

270 Repeat hepatectomy was more frequently performed in the PSH gro

271 tformin via oral gavage, after which a donor hepatectomy was performed followed by a standardized col

272 Concurrent hepatectomy was performed in 178 patients (38%), and whe

273 The right hepatectomy was performed.

274 Two weeks later completion of hepatectomy was performed.

275 The number of patient conversions to hepatectomy was seven for ACE and three for cTACE.

276 a model of liver regeneration after partial hepatectomy, we found that DN-DBC1 is down-regulated in

277 Between 2007 and 2012, a total of 680 hepatectomies were analyzed from a prospective database.

278 Between January 2013 and September 2013, 651 hepatectomies were included.

279 e 3- and 5-year overall survival rates after hepatectomy were 48.7% and 33.8%, respectively.

280 ancreaticoduodenectomy, subtotal and partial hepatectomy were analyzed.

281 Complications after donor hepatectomy were categorized using International Classif

282 who underwent elective, adult-to-adult right hepatectomy were initially screened.

283 the collaborative study period, outcomes for hepatectomy were similar for LV and HV (85 vs 507 cases)

284 rvival (RFS) and overall survival (OS) after hepatectomy were worse in patients with double mutation

285 ber of lesions, clinical-risk score, 2-stage hepatectomy) were significantly worse in the HAI group;

286 icantly different in the first 2 years after hepatectomy when the interval was extended from 3 months

287 ALPPS is a 2-stage hepatectomy, which incorporates parenchymal transection

288 Moreover, 2 reduced blood loss during liver hepatectomy, while 1 and aprotinin had no effect.

289 tients with HCC underwent various anatomical hepatectomies with the Glissonean pedicle approach betwe

290 93-4.62; P < .001), followed by extension of hepatectomy with (OR, 2.76; 95% CI, 1.85-4.77; P = .03)

291 Mice died at 15-18 days after hepatectomy with ascites, increased plasma ammonia, and

292 RASPE also allowed for extended hepatectomy with less risk of post-operative liver failu

293 nocarcinoma of right colon, underwent a left hepatectomy with ligation of right portal vein maintaini

294 Long-term outcomes after anatomical hepatectomy with the Glissonean pedicle approach in pati

295 Anatomical hepatectomy with the Glissonean pedicle approach was ach

296 the morbidity and mortality after anatomical hepatectomy with the Glissonean pedicle approach, and lo

297 ELLS during LT for PLD facilitates total hepatectomy with vena cava and caval flow preservation.

298 way were rapidly upregulated after two-third hepatectomy, with the ubiquitin ligase Nedd4-1 being a t

299 ally impedes tumorigenesis following partial hepatectomy without compromising survival or liver mass

300 ateral sectionectomy, and 3 underwent a left hepatectomy without middle hepatic vein procurement.